Drug Channels Archive for September, 2017

Click a link below to view the mailing archive as if it had been sent to you.

2017-09-28 07:41Drug Channels - Drug Channels News Roundup, September 2017: A Walgreens-Rite Aid Deal Postmortem, Impax Likes Amazon, Health Insurance History, and Gross-to-Net Bubble Emojis
2017-09-26 02:01Drug Channels - Drug Wholesalers Struggle: Slower Revenue Growth and Lower Gross Margins for 2017
2017-09-25 04:02Drug Channels - Life Sciences ACO & IDN Collaboration Summit
2017-09-19 07:15Drug Channels - Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
2017-09-18 07:35Drug Channels - CBI’s Gross-to-Net Summit
2017-09-14 07:26Drug Channels - What’s Behind the Slowdown in Specialty Pharmacy M&A Deals?
2017-09-12 07:41Drug Channels - Why Manufacturers and PBMs Should Worry About the Growth of Hospital-Owned Specialty Pharmacies
2017-09-11 07:27Drug Channels - CBI’s 9th Federal Pricing and Reporting Summit – VA * DoD * PHS
2017-09-06 07:34Drug Channels - 2016’s Fastest-Growing, Private Specialty Pharmacies (From the Inc. 5000)
2017-09-05 07:42Drug Channels - Life Sciences 2nd Annual Value-Based Contracting Summit
2017-09-01 07:16Drug Channels - The State of Specialty Pharmacy 2017: Reflections from #Asembia17 (rerun)


<< Archive IndexSubscribe >>